As part of our studies concerning the chemistry of imidazo[1,2-a]pyridine structures, 1) we are developing now a program for the design and the preparation of compounds as potential inhibitors of cytochrome P450 aromatase. Nonsteroidal aromatase inhibitors are known to prevent estrogen biosynthesis and their implication in the treatment of estrogen dependent diseases such as breast cancer is increasing.
The present study was based on the pharmacophore model designed by Rault's group 3) to fit the catalytic site of the human enzyme. This model consisted of a bicyclic skeleton bearing an azine group for interacting with the heme iron atom and an aryl group that is known to favour this interaction by occupying the extra-hydrophobic pocket located in the active site. Concomitantly, a series of 3-(azol-1-ylmethyl)-1H-indoles I revealed potent in vitro P450 aromatase inhibition (Chart 1). 4) These results led us to investigate the aromatase inhibition properties of new aryl-substituted imidazo[1,2-a]pyridine derivatives following the structural requirements of the pharmacophore model. The azole fragment was alternatively introduced on the 2-and 3-positions of the imidazo[1,2-a]pyridine leading to structures A and B. A diheteroaryl compound (structure C) was also included in this study.
Results and Discussion
The 3-hydroxymethylation of 2-phenylimidazo[1,2-a]pyridine 1 5) was easily achieved using reaction with formaldehyde and sodium acetate in acetic acid media according to our previously described procedure.
6) The transformation of the expected alcohol 2 into the azolyl compounds 3a-b was carried out through a treatment with refluxing thionyl chloride, followed by attack of the intermediary chloro derivative with imidazole or triazole in acetonitrile at 50°C for 48 h (Chart 2). The structure of the imidazolyl compound 3a was easily demonstrated from NMR spectra. In the case of triazole derivative the 1 and 4 regioisomers could be formed. Usually the N-4 isomer gives a single signal in 1 H-and 13 C-NMR while the N-1 derivative gives two signals for H-3Ј/C-3Ј and H-5Ј/C-5Ј. 7) The 1 H-NMR spectrum of 3b in CDCl 3 presented a singlet at d 8.05 for H-3Ј and H-5Ј while C-3Ј and C-5Ј resonate at d 152.3 and 142.4. The ambiguity was solved by performing the 1 H-NMR spectrum in DMSO-d 6 that gave two singlets at d 8.02 and 8.87 confirming 3b to be the N-1 isomer.
Our second investigation was to incorporate the aryl group on the 3-position followed by the introduction of an imidazole ring on the 2-position to provide the geometric isomers.
Commercially available ethyl 2-oxo-4-phenylbutyrate was readily brominated to give the a-bromocarbonyl intermediate 4 which was condensed as previously described 5) with 2-aminopyridine to yield 5 (Chart 3). Synthesis of the lesser homologue 8 through the same synthetic pathway was difficult due to the troublesome access to the ethyl 2-oxo-3-phenylpropanoate. Recently 3-arylation of imidazo[1,2-a]pyridine was achieved using Stille conditions 8) while we have studied the palladium catalyzed Suzuki-type cross coupling reaction. 9) We chose our strategy to introduce the 3-phenyl ring starting from the appropriate iodo intermediate 7 (Chart 4). This compound was obtained from ethyl imidazo[1,2-a]pyridine-2-carboxylate 6 using iodine in pyridine 10) in 46% yield. 13 C-NMR spectrum of 7 was characterized by the C-3 signal high field shielding to 68 ppm. Suzuki reaction was performed using phenylboronic acid in the presence of sodium carbonate in DME at 75°C for 0.5 h to give 8 (91% yield).
9)
The ester function of 5 and 8 was reduced using lithium aluminium hydride in tetrahydrofuran at room temperature for 1 h (Chart 5). Proof of the structure was found in 1 H-NMR spectra. Depending on the CDCl 3 solution concentration, a variation of 0.4 ppm could be observed for the H-8 signal due to the formation of a hydrogen bond between the hydroxyl group and the N-1 atom. The substitution of the expected alcohols 9a-b into the 2-(imidazol-1-ylmethyl)imidazo[1,2-a]pyridines 10a-b was carried out using the synthetic pathway reported for 3a-b.
Finally, in order to prepare diheteroaryl derivatives, we have changed the phenyl ring of 10b to a pyrrole fragment (Chart 6). The 2-chloromethyl-3-nitroimidazo[1,2-a]pyridine 11 11) was first substituted with imidazole in acetonitrile and then reduced with tin in hydrobromic acid media.
12) The expected aminoderivative 13 was then involved in a ClausonKaas reaction, 13) using 2,5-dimethoxytetrahydrofuran in acetic acid but 2-(imidazol-1-ylmethyl)-3-(pyrrol-1-yl)imidazo[1,2-a]pyridine 14 was obtained in only poor yield.
With a view to further developing the structure-activity relationship study, we were then interested in the crystallographic data for one of the synthesized compounds. Our studies were focused on derivatives of structure B and a crystal of compound 10b was obtained.
Crystal Structure The fractional coordinates and the equivalent thermal factors (U eq ) are listed in Table 1 . The thermal ellipsoid representation and the labelling of nonhydrogen atoms of both conformations for one molecule is presented in Fig. 1. 14) The bond lengths and bond angles are given in Tables 2 and 3 respectively and agree quite well with the literature.
15) The interesting torsion angles which entirely define the molecule conformation are reported in Table 4 .
The imidazo[1,2-a]pyridine ring ø1 (atoms N1 to C8A), imidazole ring ø2 (atoms N1Ј to C5Ј), and phenyl ring ø3 (atoms C1Љ to C6Љ) are planar with the dihedral angles reported in Table 5 .
The packing of the molecule is shown in Fig. 2 . There are numerous weak van der Waals interactions so the crystal cohesion is assumed through several hydrogen bonds (Fig. 3) . The molecule I is involved in the following hydrogen bond between the OH group and N atoms ( Table 6 ).
Conclusion
The present paper deals with the synthesis of 2,3-disubstituted imidazo[1,2-a]pyridine derivatives as potential aromatase inhibitors. On the basis of a pharmacophore model three types of structures were designed. From the synthesized compounds the crystal data obtained from 10b was studied. Unfortunately the spatial structure showed the compound does not fit well with the proposed pharmacophore. This result was ascertained by determining the inhibition of the enzyme in vitro which showed that these compounds are inactive. Despite this fact, the crystal data of 10b serve as a start point in the design of further derivatives.
Experimental
Melting points were determined on a Kofler block and are uncorrected. H-NMR and 13 C-NMR spectra were recorded on a Brüker DPX 200 MHz (50 MHz for 13 C). Splitting patterns have been designated as follows: sϭsin-glet; bsϭbroad singlet; dϭdoublet; tϭtriplet; qϭquartet; ddϭdouble doublet; mϭmultiplet. Analyses indicated by the symbols of the elements were within Ϯ0.5% of the theoretical values. The organic solutions were dried over anhydrous calcium chloride. Previously reported imidazo[1,2-a]pyridines synthesized by the described procedure were: 2-phenylimi-
11) Possible inversion of two values in the NMR spectra is expressed by an asterisk.
Ethyl 3-Bromo-2-oxo-4-phenylbutyrate (4)
To a solution of ethyl 2-oxo-4-phenylbutyrate (5 g, 24.2 mmol) in chloroform (30 ml) was added dropwise bromine (1.24 ml, 24.2 mmol). After stirring for 1 h at room temperature, the reaction mixture was washed with water (3ϫ20 ml), dried and concentrated in vacuo to give a translucent oil (87%); To a solution of 6 (3 g, 15.8 mmol) in pyridine (10 ml) was added iodine (6 g, 23.6 mmol). The reaction mixture was heated at 50°C for 5 h and then poured into water (20 ml). The aqueous solution was extracted with dichloromethane. The combined organic extracts were washed with water (3ϫ20 ml), dried and evaporated to dryness. The residual material was purified by column chromatography (neutral alumina, dichloromethane as eluant) to give brown General Procedure for (Imidazo[1,2-a]pyridin-2-yl)methanol Derivatives To a stirred solution of 5 or 8 (6 mmol) in THF (15 ml) was added a suspension of lithium aluminium hydride (12 mmol) in THF (5 ml). After 1 h, water (20 ml) was added dropwise and then the reaction media filtered off. The filtrate was extracted with dichloromethane and the dried organic layers were evaporated to dryness to give white crystals.
( General Procedure for Arylmethylimidazo[1,2-a]pyridine Derivatives A solution of imidazo[1,2-a]pyridinylmethanol derivative 2 or 9a-b (6 mmol) in thionyl chloride (20 ml) was refluxed for 2 h. After evaporation to dryness, the chloro derivative was washed with petroleum ether (2ϫ 50 ml), poured into acetonitrile (20 ml) and imidazole or triazole (13.2 mmol) was added. After 48 h of stirring at 50°C, the solution was concentrated in vacuo and the residue diluted in water (20 ml). The solution was extracted with dichloromethane, the dried organic layers evaporated to dryness and the residue was chromatographed on neutral alumina eluting with dichloromethane.
3 11) (3 g, 14.2 mmol) and imidazole (2.1 g, 30.8 mmol) in acetonitrile (15 ml) was stirred at 50°C for 24 h. After removal of the solvent in vacuo, the reaction mixture was diluted in water (50 ml) and extracted with dichloromethane (2ϫ50 ml). The dried organic layers were evaporated to dryness and the oily residue triturated in diethyl ether to give a brown solid (43%); 5 mmol) and dimethoxytetrahydrofuran (0.46 ml, 3.5 mmol) in acetic acid (20 ml) was heated at 90°C for 2 h. After removal of the solvent in vacuo, the residue was triturated in diethyl ether (75 ml). After filtration, the filtrate was dried over magnesium sulfate and evaporated to dryness. The residue was chromatographed on neutral alumina eluting with dichloromethane to give 14 as white crystals (13%); mp 153°C; 1 . The linear absorption coefficient is mϭ0.717 mm
Ϫ1
for the CuKa radiation.
The diffracted intensities were collected with a CAD-4 Enraf-Nonius diffractometer equiped with a graphite monochromator for q max ϭ65°: 0ՅhՅ10, Ϫ11ՅkՅ11, Ϫ21ՅlՅ21 and an wϪ2q scan. Two standard reflections (3 0 Ϫ10, 0 Ϫ5 Ϫ10) were used to monitor the data collection and detect any decrease of intensity; the crystal absorption correction was performed using the Y scan technique. 19) There were 5316 independent reflections of which 4898 were considered as observed (IϾ2s(I ) and R int ϭ0.012).
The crystal structure was solved and refined using the SHELX97 program. 20) Scattering factors were taken from the International Tables for  Crystallography. 21) The hydrogen atoms were introduced in their theoretical positions and allowed to ride with the atoms to which they are attached. 
